Evidence map›Paper›PMID 29330547›Full record

ArticleEuropean journal of human genetics : EJHG2018

Recessive loss of function PIGN alleles, including an intragenic deletion with founder effect in La Réunion Island, in patients with Fryns syndrome.

Jean-Luc Alessandri, Christopher T Gordon, Marie-Line Jacquemont, Nicolas Gruchy, Norbert F Ajeawung, Guillaume Benoist, Myriam Oufadem, Asma Chebil, Yannis Duffourd, Coralie Dumont and 16 more

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in European journal of human genetics : EJHG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. EDIR: exome database of interspersed repeats.Bioinformatics (Oxford, England) · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 2 countries.

Jean-Luc AlessandriService de Réanimation Néonatale, Pole Femme-Mère-Enfant, CH Felix Guyon, CHU de La Réunion, Saint-Denis, La Réunion, France. jean-luc.alessandri@chu-reunion.fr.
Christopher T GordonLaboratory of embryology and genetics of congenital malformations, INSERM UMR 1163, Institut Imagine, Paris, France.ORCID http://orcid.org/0000-0002-9300-8399
Marie-Line JacquemontUnité de Génétique Médicale, Pole Femme-Mère-Enfant, Groupe Hospitalier Sud Réunion, CHU de La Réunion, La Réunion, France.
Nicolas GruchyService de Génétique, UFR Santé Caen, Caen, France.
Norbert F AjeawungCentre de Recherche du CHU Sainte-Justine et Université de Montréal, Montréal, QC, Canada.
Guillaume BenoistService de Génétique, UFR Santé Caen, Caen, France.
Myriam OufademLaboratory of embryology and genetics of congenital malformations, INSERM UMR 1163, Institut Imagine, Paris, France.
Asma ChebilService de Gynécologie-Obstétrique, CH Mamoudzou, Mayotte, France.
Yannis DuffourdINSERM UMR 1231 GAD team, Genetics of Developmental Anomalies, Université de Bourgogne-Franche Comté, Dijon, France.
Coralie DumontService de Gynécologie-Obstétrique, Pole Femme-mère-Enfant, Groupe Hospitalier Sud Réunion, CHU de La Réunion, La Réunion, France.
Marion GérardService de Génétique, UFR Santé Caen, Caen, France.
Paul KuentzINSERM UMR 1231 GAD team, Genetics of Developmental Anomalies, Université de Bourgogne-Franche Comté, Dijon, France.ORCID http://orcid.org/0000-0003-2814-6303
Thibaud JouanINSERM UMR 1231 GAD team, Genetics of Developmental Anomalies, Université de Bourgogne-Franche Comté, Dijon, France.
Francesca FilippiniLaboratory of embryology and genetics of congenital malformations, INSERM UMR 1163, Institut Imagine, Paris, France.
Thi Tuyet Mai NguyenCentre de Recherche du CHU Sainte-Justine et Université de Montréal, Montréal, QC, Canada.
Olivier AlibeuInstitut Imagine, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Christine Bole-FeysotInstitut Imagine, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Patrick NitschkéInstitut Imagine, Paris Descartes-Sorbonne Paris Cité University, Paris, France.
Asma OmarjeeService de Gynécologie-Obstétrique, Pole Femme-mère-Enfant, Groupe Hospitalier Sud Réunion, CHU de La Réunion, La Réunion, France.
Duksha RamfulService de Réanimation Néonatale, Pole Femme-Mère-Enfant, CH Felix Guyon, CHU de La Réunion, Saint-Denis, La Réunion, France.
Hanitra RandrianaivoUnité de Génétique Médicale, Pole Femme-Mère-Enfant, Groupe Hospitalier Sud Réunion, CHU de La Réunion, La Réunion, France.
Bérénice DorayService de Génétique, CH Félix Guyon, CHU de La Réunion, La Réunion, France.
Laurence FaivreINSERM UMR 1231 GAD team, Genetics of Developmental Anomalies, Université de Bourgogne-Franche Comté, Dijon, France.
Jeanne AmielLaboratory of embryology and genetics of congenital malformations, INSERM UMR 1163, Institut Imagine, Paris, France.
Philippe M CampeauCentre de Recherche du CHU Sainte-Justine et Université de Montréal, Montréal, QC, Canada.
Julien ThevenonINSERM UMR 1231 GAD team, Genetics of Developmental Anomalies, Université de Bourgogne-Franche Comté, Dijon, France.
Centre Hospitalier Universitaire de La Réunion · FRDélégation Paris 5 · FRInserm · FRCentre Hospitalier Universitaire Sainte-Justine · CAUniversité de Caen Normandie · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fryns syndrome (FS) is a multiple malformations syndrome with major features of congenital diaphragmatic hernia, pulmonary hypoplasia, craniofacial dysmorphic features, distal digit hypoplasia, and a range of other lower frequency malformations. FS is typically lethal in the fetal or neonatal period. Inheritance is presumed autosomal recessive. Although no major genetic cause has been identified for FS, biallelic truncating variants in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or compound missense with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of function PIGN alleles, including an intragenic deletion with a likely founder effect in La Réunion and other Indian Ocean islands. Our results support the hypothesis that a spectrum of phenotypic severity is associated with recessive PIGN variants, ranging from FS at the extreme end, caused by complete loss of function, to MCAHS1, in which some residual PIGN function may remain. Our data add FS resulting from PIGN variants to the catalog of inherited GPI deficiencies caused by the disruption of the GPI-anchor biosynthesis pathway.

Indexed as

Founder EffectLoss of Function MutationFaciesFemaleGene DeletionHernia, DiaphragmaticHumansInfantInfant, NewbornLimb Deformities, CongenitalMalePhosphotransferasesPhosphotransferasesPIGN protein, human

Identifiers

PMID29330547
PMCPMC5839001
OpenAlexW2784255800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.